Increased growth factor-mediated mitogenic signaling through key oncogenic pathways, such as hyperactive PI3K and MAPK pathways, can also assist cancer cells in bypassing the RB-dependent restriction point in the G1 phase of the cell cycle by promoting Cyclin D-CDK4/6 activity (Figure 1) [69]. This evidence concerns the gene CDK4 and cancer.